Doctor of Dentistry Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Delis Ogando

Advanced Practice Dental Therapist Jackson, MI Doctor of Dentistry

NPI 1730619438 CMS profile 2914584

505 N Jackson St, Jackson, MI 49201

Open in the dashboard

General payments

$961

22 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Delis Ogando of Jackson, MI is reported in the CMS Open Payments database as having received $961 across 22 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $288 9
2024 General $307 4
2023 General $269 2
2022 General $82 6
2020 General $16 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Delis Ogando
  • Michigan median
  • Middle half of Michigan
  • National median

In program year 2025, general payments to Delis Ogando were reported at $288. Among 33,118 Michigan profiles paid that year, the median was $162 and the middle half received between $49 and $568.

Show as a table
Year Delis Ogando Michigan median Middle half National median
2019 $0 $153 $47–$580 $163
2020 $16 $108 $35–$342 $114
2021 $0 $124 $35–$428 $132
2022 $82 $142 $43–$509 $149
2023 $269 $150 $46–$530 $160
2024 $307 $157 $47–$545 $164
2025 $288 $162 $49–$568 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Kulzer, LLC $351 5 payments
  2. Sonendo Inc $255 1 payment
  3. Straumann USA LLC $187 6 payments
  4. Dentsply Sirona Inc $83 4 payments
  5. Coltene Whaledent Inc. $32 3 payments
  6. Envista Holdings Corporation $24 1 payment
  7. GC America Inc. $16 1 payment
  8. Philips Electronics North America Corporation $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $937 21 payments
  2. Grant $24 1 payment
Products named General payments · program years 2020–2025
  1. GentleWave G4 Console $255 1 payment
  2. FLEXITIME XTREME 2 CORRECT FLOW 12 PC $71 1 payment
  3. SureSmile $34 2 payments
  4. WaveOne Gold Conform Fit $32 1 payment
  5. IBOND TOTAL ETCH BOTTLE VALUE PACK $24 1 payment
  6. HARMONIZE $24 1 payment
  7. Prime&Bond NT Nano-Technology Light Cured Dental Adhesive $18 1 payment
  8. Fujicem Evolve $16 1 payment
  9. Equia Forte HT $16 1 payment
  10. G-aenial Universal Injectable $16 1 payment
  11. Other $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

95

Prescriptions dispensed, refills included

Drug cost

$320

Paid at the pharmacy, in all

Branded share of claims

0%

Brand-name drugs, not generics

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 37 $136
Ibuprofen Generic 35 $100
Chlorhexidine Gluconate Generic 23 $84

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.

Records

22 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record